A well-known Pittsburgh medical practice has been ordered to pay a fine following a guilty plea involving the purchase of unapproved, foreign pharmaceuticals.
Jan C. Seski, M.D. & Associates, an oncology practice, pleaded guilty Thursday in federal court in California to a criminal charge of having cause the introduction of an unapproved drug into interstate commerce. The practice was ordered to pay a $100,000 fine and also to place advertisements in two medical journals, warning of the dangers of unapproved drugs.
The guilty plea was announced by U.S. Attorney Laura E. Duffy of the Southern District of California in San Diego.
In pleading guilty before U.S. Magistrate Judge Karen S. Crawford, the medical practice admitted that between
December 4, 2008, and May 25, 2011, the practice ordered $973,795 worth of foreign versions of the oncology drugs Eloxatin7, Gemzar7 and Taxotere7 from GlobalRxStore.com, and had them shipped through
Oberlin Medical Supply of San Diego. The drugs ordered by the practice were determined to be foreign versions of these drugs and were not approved by the U.S. Food and Drug Administration for use in the United States.
According to sentencing documents filed with the court, the case came to light in May 2011 when federal agents visited Oberlin Medical Supply offices in San Diego. Agents discovered numerous boxes of oncology drugs that bore labeling indicating that the products had been manufactured outside of the United States and were not approved for use in this country.
Dr. Seski is considered a pioneer in the practice of what's known as bloodless surgery.